Kai‐Henrik Peiffer

1.4k citations
47 papers · 734 indexed · 1 hit paper · h-index 14
Topics
Hepatitis C virus research (30 papers)Liver Disease Diagnosis and Treatment (24 papers)Hepatitis B Virus Studies (24 papers)
Partner nations
GermanySpainBelgium

In The Last Decade

Kai‐Henrik Peiffer

44 papers receiving 722 citations

Hit Papers

Combining ferroptosis induction with MDSC blockade render...2023202620242025202350100150

Peers

Kai‐Henrik Peiffer
Comparison fields: 5 of 74
  • Hepatology 468
  • Epidemiology 463
  • Molecular Biology 133
  • Pulmonary and Respiratory Medicine 117
  • Cancer Research 92
Replace Harald Farnik with:
Harald Farnik Germany
Xiaoguang Dou China
Chan Ran You South Korea
Hee Sik Sun South Korea
Lubiao Chen China
Takuya Sho Japan
Te‐Sheng Chang Taiwan
June Sung Lee South Korea
Klaus Boeker Germany
Hanno Ehlken Germany
Kai‐Henrik Peiffer relative to Harald Farnik Germany Harald Farnik's profile →
Citations per field
00.5×6.1×
Harald Farnik · 1×
Citations per year

Countries citing papers authored by Kai‐Henrik Peiffer

Since Specialization
Citations

This map shows the geographic impact of Kai‐Henrik Peiffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai‐Henrik Peiffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai‐Henrik Peiffer more than expected).

Fields of papers citing papers by Kai‐Henrik Peiffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai‐Henrik Peiffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai‐Henrik Peiffer. The network helps show where Kai‐Henrik Peiffer may publish in the future.

Co-authorship network of co-authors of Kai‐Henrik Peiffer

This figure shows the co-authorship network connecting the top 25 collaborators of Kai‐Henrik Peiffer. A scholar is included among the top collaborators of Kai‐Henrik Peiffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai‐Henrik Peiffer. Kai‐Henrik Peiffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 3
3 1
4 3
5 6
6 2
7 1
8 1
9 5
10
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockadebreakdown →
176
11 3
12
SAFETY AND PRELIMINARY EFFICACY AND PHARMACOKINETICS OF INTRAPERITONEAL VS-01 INFUSIONS IN PATIENTS WITH DECOMPENSATED LIVER CIRRHOSIS: A FIRST-IN-HUMAN, OPEN-LABEL, PHASE 1b CLINICAL TRIAL
1
13 10
14 7
15 5
16 5
17 17
18 22
19 33
20 2

About Kai‐Henrik Peiffer

Kai‐Henrik Peiffer is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 47 papers that have together received 734 indexed citations. Recurring topics across this work include Hepatitis C virus research (30 papers), Liver Disease Diagnosis and Treatment (24 papers) and Hepatitis B Virus Studies (24 papers). The work is most often cited by research in Hepatology (468 citations), Epidemiology (463 citations) and Cancer Research (92 citations). Kai‐Henrik Peiffer has collaborated with scholars based in Germany, Spain and Belgium. Frequent co-authors include Stefan Zeuzem, Christoph Sarrazin, Johannes Vermehren, Fabian Finkelmeier, Christoph Welsch, Tania M. Welzel, Georgios Grammatikos, Nina Weiler, S. Süsser and Marcus M. Mücke. Their work appears in journals such as PLoS ONE, Hepatology and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026